Related Experiment Video
Updated: Jul 29, 2025

Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials
Published on: May 31, 2024
Neuromodulator Finesse for Masseter Hypertrophy and Bruxism
Michael V Chiodo1, Jeffrey L Lisiecki1, Rod J Rohrich1,2
1From the Dallas Plastic Surgery Institute.
Hypertrophied masseter muscles can cause a wide face and discomfort. Neuromodulator injections are a primary treatment for masseter reduction and bruxism, with this article detailing an effective injection technique.
Area of Science:
- Plastic Surgery
- Anatomy
- Neurology
Background:
- Prominent mandibular angles or masseter hypertrophy can lead to a wide facial appearance.
- While often benign and aesthetic, masseter hypertrophy can cause pain, bruxism, and headaches.
Purpose of the Study:
- To present a detailed anatomic approach for neuromodulator injection of the masseter muscle.
- To provide a visual guide through a corresponding video of the injection technique.
Main Methods:
- Anatomic dissection and injection mapping.
- Neuromodulator administration targeting specific masseter muscle regions.
- Video documentation of the injection procedure.
Main Results:
- The presented technique facilitates precise neuromodulator delivery for masseter reduction.
- The method addresses both aesthetic concerns and functional issues like bruxism.
Conclusions:
- Neuromodulator therapy is a first-line treatment for masseter reduction and bruxism.
- The described anatomic approach offers a reproducible and effective method for masseter neuromodulator injections.
More Related Videos
06:46In Vivo Functional Assessment of Rat Masseter Muscle Following Surgical Creation of a Volumetric Muscle Loss (VML) Injury
Published on: November 15, 2024
19:53Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...